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Abstract 
Background: Over the last 50 years several studies have provided estimates of the 
prevalence of transsexualism. The variation in reported prevalence is considerable and 
may be explained by factors such as the methodology and diagnostic classification 
used and the year and country in which the studies took place. Taking these into 
consideration, this study aimed to critically and systematically review the available 
literature measuring the prevalence of transsexualism as well as performing a meta-
analysis using the available data.  
Methods: Databases were systematically searched and 1473 possible studies were 
identified. After initial scrutiny of the article titles and removal of those not relevant, 
250 studies were selected for further appraisal. Of these, 211 were excluded after 
reading the abstracts and a further 18 after reading the full article. This resulted in 21 
studies on which to perform a systematic review, with only 12 having sufficient data 
for meta-analysis. The primary data of the epidemiological studies were extracted as 
raw numbers. An aggregate effect size, weighted by sample size, was computed to 
provide an overall effect size across the studies. Risk ratios and 95% confidence 
intervals (CIs) were calculated. The relative weighted contribution of each study was 
also assessed. 
Results: The overall meta-analytical prevalence for transsexualism was 4.6 in 
100,000 individuals; 6.8 for trans women and 2.6 for trans men. Time analysis found 
an increase in reported prevalence over the last 50 years. 
Conclusions: The overall prevalence of transsexualism reported in the literature is 
increasing. However, it is still very low and is mainly based on individuals attending 
clinical services and so does not provide an overall picture of prevalence in the 
general population.  However, this study should be considered as a starting point and 
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the field would benefit from more rigorous epidemiological studies acknowledging 
current changes in the classification system and including different locations 
worldwide. 
 
Keywords: Gender Dysphoria, transgender, population, systematic review, meta-
analysis 
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1. Introduction 
Transsexualism, as defined by the International Classification of Disease (ICD-10)(1) 
and the previous editions of the Diagnostic and Statistical Manual of Mental 
Disorders(2,3), describes individuals who experience discomfort or distress caused  by 
the discrepancy between  their  gender identity and the sex they were  assigned  at  
birth. When this distress is sufficiently intense individuals wish to transition from one 
point on a notional gender scale to another – most commonly from a man to a woman 
(people known as trans women) or from a woman to a man (people known as trans 
men(4,5). The diagnosis of transsexualism according to the ICD-10(1) is currently under 
revision.  It is proposed that the new edition of the ICD (ICD-11) will include a new 
diagnostic term and will also include individuals who do not fit into the gender binary 
category(6), as is the case in the DSM-5(7). 
 
To estimate the prevalence of trans individuals is relevant for health service 
development and policymaking, although this can be complex due to several factors. 
Some of those factors relate to the complexity of undertaking general prevalence 
studies, i.e. the fact that diagnoses change over the years or that results differ 
depending on the period of time used to collect data. For example, point prevalence is 
a measure of the proportion of people in a given population at an exact time point, 
such as a particular date, which is in contrast to period prevalence that measures the 
proportion of people in a given population over a specific time period, for example 
several years(8).  
 
Other factors that also add to the complexity of undertaking epidemiological studies 
relate to the subject studied; in this case the number of transsexual individuals in the 
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community. For example, the terminology and classification systems used have varied 
over the years, and authors have used some of this terminology inconsistently, for 
example, Gender Identity Disorder, Gender Dysphoria, or Transsexualism.  
 
Nevertheless, it is reassuring (in relation to performing this meta-analysis) to find that 
there are many epidemiological studies that have used the term “transsexualism” and 
which have followed the ICD or DSM diagnostic criteria (9,1,2,3,10,11,7) or the definition 
developed by Benjamin in 1966(12), which requires all of the following:  
1) A sense of belonging to the opposite sex, of having been born into the wrong 
sex, or being one of nature’s extant errors. 
2) A sense of estrangement from one’s own body: all indications of sex 
differentiation are considered as afflictions and repugnant. 
3) A strong desire to resemble physically the opposite sex via therapy, including 
surgery. 
4) A desire to be accepted by the community as belonging to the opposite sex. 
 
The definition of transsexualism is different in the DSM-IIIR(3). This edition of the 
diagnostic criteria did not include those individuals who were not interested in 
undergoing sex reassignment surgery and who received the alternative diagnosis of 
Gender Identity Disorder of Adolescents and Adulthood, Nontranssexual Type 
(GIDAANT). This great variation in how transsexualism is defined in different 
studies (based on the diagnostic criteria used at the time that the study took place) will 
clearly affect the reported prevalence. 
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A second complexity in developing true epidemiological studies of transsexualism 
relates to the methods used to identify this population. For example, the country 
where the study takes place can influence the prevalence of individuals found, as trans 
people tend to live in larger cities and especially in areas, or countries, which are 
defined as “trans friendly”(13). Therefore studies from specific countries may describe 
a high prevalence of transsexual individuals, which may not be generalizable to other 
countries.  Thirdly, the timing of the study may also affect the findings. The fact that 
in some countries tolerance to trans individuals has improved over the years has 
allowed trans people to “come out” more easily in order to access clinical services (14, 
15).  This may be reflected by the fact that older studies(16) report lower prevalence 
than more recent ones(17). Finally, the recruitment process used to collect 
epidemiological data will also influence the findings. Many studies are based on 
clinical populations of individuals which, by definition, only include those who have 
the capacity and motivation to ask for help, but, importantly, can also access clinical 
services(18). This is reflected in the large number of studies from the Netherlands(18,19) 
where trans services have been available for many years and where society is 
generally tolerant (14, 15). 
 
Therefore, as highlighted by the WPATH Standards of Care(20) and other authors(21) 
efforts to formally calculate the prevalence of transsexualism present with enormous 
difficulties, due to the differences in cultural manifestation of gender behavior. It is 
because of this that researchers who have studied prevalence rates have focused on 
the most easily counted subgroup of gender-nonconforming people - those who 
present for gender-transition-related care at specialist gender identity clinics(21). As a 
consequence many prevalence studies published in this field have their origins in the 
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Western world(22). There is only one prevalence study from the Eastern world(23), 
which is surprising given that many countries like Thailand, India and Pakistan are 
known to have an apparently tolerant culture towards trans* identities, although there 
are many ethnographic related studies(24,25,26). 
The large number of studies investigating prevalence of transsexual individuals, and 
reviewed in this study, provide the best available insight into the rates of 
transsexualism, and vary from 0.45(22) to 23.6(23) per 100,000 people. Although 
prevalence studies are welcome, such a great variation in findings leaves the reader 
confused. Therefore, the aim of this study was to respond to the reported variation in 
prevalence by critically and systematically reviewing prevalence studies in 
transsexualism.  Where data were available, a meta-analysis of the studies was carried 
out which took population, diagnosis, the time period studied and gender into 
consideration.   
 
2. Methods 
 
2.1. Search strategy 
This meta-analytic review adheres to the guidelines detailed in the PRISMA 
Statement(27). A systematic literature search, appraisal and meta-analysis was 
conducted using a broad range of subject headings in order to identify relevant 
prevalence studies in the field. The following data bases were used: Web of Sciences, 
Medline/Pubmed, Biosis, Science Direct, and Scielo. For each database, combinations 
of the following search components were used: Transsexual, Transgender, Gender 
Dysphoria, Gender Identity Disorder, Gender non conforming, Gender Variant, 
epidemiology, incidence, and prevalence. Studies published between 1945 and June 
9 
 
2014 were selected. Two researchers independently selected the studies, extracted the 
data, cross-checked them and resolved disagreements. Case studies or studies 
describing small populations of individuals which could not be proved to reflect the 
prevalence of a given area, region or country were excluded. Only studies describing 
adolescent or adult populations were included. Reference lists of relevant articles 
were screened for further potential studies and citation searches were conducted. Only 
studies describing transsexualism as per Benjamin(12), ICD(1,9) or DSM(2,3,7,10,11) 
definitions were selected. Table 1 details the criteria for search used for this review.  
 
Table 1 insert around here 
 
When the study did not describe some of the above information, whenever possible, 
this was calculated by the authors. For example, in some cases the mean population of 
the studied area was calculated. Studies were excluded where there was ambiguity in 
the number of individuals with a clear diagnosis or studies that primarily included 
individuals who were self-diagnosed or had not been diagnosed by a professional(19, 
28).  
 
2.2. Procedure  
Studies meeting the inclusion criteria were examined. The study collected the 
available information for the following outcomes of interest: 1) prevalence of 
transsexual individuals in general per 100,000 individuals; 2) prevalence of trans 
women per 100,000 individuals; 3) prevalence of trans men per 100,000 individuals; 
4) sex ratio between males and females; 5) country or region where the study took 
place; 6) number of years during which information was collected; 7) information 
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regarding methods used to identify trans individuals; and 8) the change in the trans 
men/trans women ratio as a function of time (descriptive information).  
 
2.3. Included and excluded studies  
Studies were screened in three phases, namely title, abstract, and full text. In the first 
instance the titles were screened (n= 1724). The number of studies found using the 
above search terms were: Transgender (TG) plus epidemiology (259), TG plus 
incidence (28) and TG plus prevalence (257). Transsexualism (TS) plus epidemiology 
(143), TS plus incidence (51) and TS plus prevalence (130); Gender dysphoria (GD) 
plus epidemiology (24), GD plus incidence (4), GD plus prevalence (11); Gender 
identity disorder (GID) plus epidemiology (390), GID plus incidence (41) and GID 
plus prevalence (384). Gender non conforming (GNC) plus epidemiology (1), GNC 
plus incidence (0) and GNC plus prevalence (1).   Duplicates were removed (n=251), 
and the two independent reviewers (JA and GW) independently screened and coded 
the remaining titles (n=1473). Based on the titles, 1223 papers were excluded. The 
main reason for exclusion was that the studies did not describe prevalence of 
Transsexualism, Gender Identity Disorder or Gender Dysphoria, but prevalence of 
other disorders such as mental health problems or HIV in trans individuals. Out of the 
250 studies selected to be screened in detail, 211 were excluded after reading the 
abstracts. The reasons for the exclusions were: inadequate sample size (case studies); 
2) no prevalence data; and 3) no specific area, region or country covered by the study. 
Out of the 39 papers retrieved for more detailed evaluation, five were excluded as 
there was no exact epidemiological information or they were not covering a specific, 
identifiable area (these were not excluded in the previous stage as this information 
was not identifiable by reading the abstract). Four more studies were excluded as they 
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only described the prevalence of psychiatric co-morbidity, and a further five studies 
were excluded as the population was self-identified or it was unclear as to whether the 
participants fulfilled diagnostic criteria. In addition, a case study, a general review on 
the etiology of transsexualism (with no new data), and two studies that described only 
children were also excluded. In total 21 studies were systematically reviewed.  
 
Insert figure 1 around here 
 
2.4.Assessment of quality  
The study used a checklist for cross sectional studies based on the NICE checklists (29) 
developed by Gilbert(30) and used in previous studies(31). The NICE rating system rates 
the studies from good quality (when all or most of the criteria have been fulfilled; 
[++]), reasonable quality (when some of the criteria have been fulfilled; [+]), to poor 
quality (when few or no criteria are fulfilled; [-]). The review and scoring was based 
on the quality of the study reporting prevalence of transsexualism. Some of the 
studies were qualitatively excellent but reported prevalence of sex reassignment 
surgery instead of transsexualism. In these cases, studies were scored as +* to indicate 
this.  
 
2. 5. Statistical analysis 
To calculate the meta-analytical prevalence, only studies that reported new data were 
included. When several studies used the same data but at different times (i.e., data 
from clinical databases across years), only the newest point prevalence data was 
selected. In contrast, to calculate time series analysis, information from studies 
describing period prevalence were included and the mean year of the studied period 
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was used as a moderator for the analysis.  For studies that spanned several years, the 
total number of cases (trans men, trans women) were divided by the number of years 
covered by the study in order to calculate the prevalence per year. Any missing 
information was estimated. 
 
The primary data of the epidemiological studies were extracted as raw numbers. An 
aggregate effect size, weighted by sample size, was computed to provide an overall 
effect size across the studies. Homogeneity among studies was computed using the Q 
statistic and the I2 statistic. A significant Q statistic suggests that the distribution of 
effect size around the mean is greater than would be predicted from sampling error 
alone, whereas I2 provides an estimate of the proportion of the variance in the 
aggregate effect size that is attributable to between-studies heterogeneity(32). Random-
effects models were fitted if there was heterogeneity. Risk ratios and 95% confidence 
intervals (CIs) were calculated. The relative weighted contribution of each study was 
also assessed. Meta-analysis was performed using the Comprehensive Meta-Analysis 
software programme-2 for Windows(33) according to the Cochrane reviewers’ 
handbook(34).  Significance was set at p < 0.05. 
 
3. Results 
3.1. Study characteristics 
Most of the studies published were from Europe (18; 85.7%): five from Sweden (17, 22, 
35, 36, 37), three from the Netherlands(18, 38, 39), 
 three from the United Kingdom(40, 41, 42), 
two from Germany(13, 43) and one each from Spain(44), Belgium(45), Serbia(46), 
Ireland(47), and Poland(48). There was only one study from the United States of 
America (USA), which was also the oldest(16), only one from Singapore(23), and only 
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one from Australia(49). Most of the studies from the same country, such as the Dutch 
and the Swedish studies, used the same data but at different periods therefore 
covering different years. Other studies from the same country focused on different 
areas, regions or counties within the country, such as East and West Germany, and 
Northern Ireland, Scotland or England (three from the United Kingdom). The study 
period varied from three years(22) to an impressive 50 years(17).
 
 
Employing the NICE rating system described above, there were four studies that were 
scored as (-). This was because they were particularly old studies reporting 
epidemiological data calculated from approximations(16), or from information 
collected from third parties (such as psychiatrists via questionnaires(50), or from 
primary care(42)). They were also rated as (-) if the information regarding how 
individuals could access the gender clinic and whether the clinic covered a specific 
geographical area was unclear(48). Six studies scored (+) as although methodologically 
strong,  the information was gathered from third parties (courts or government(28, 43), 
endocrinologists(47) or surgeons(45)), or the geographical area covered was unclear(40, 
41) . Two studies that focused specifically on sex reassignment surgery were scored as 
(+*)(17, 46). The rest of the studies scored (++) as they were methodologically strong 
and provided clear epidemiological information regarding the prevalence of 
transsexualism in the specific country, based on individuals attending a gender 
identity clinic. Most of the studies were from the same countries, such as the 
Netherlands and Sweden. 
 
3.2. Population studied  
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All of the 21 studies selected for the systematic review defined the population studied 
as transsexual individuals. The majority of the studies used data gathered 
retrospectively from gender identity clinics. The clinics covered the whole of their 
countries, such as the Netherlands(18), or a specific geographical area within the 
country, such as Catalonya in Spain(44). The studies used the ICD(1), DSM(2,3) or 
Benjamin’s(12)  criteria to define the population.  
 
The reviewed studies provided reliable data and identified a population of transsexual 
individuals in the following way: seven studies described individuals referred to a 
gender identity clinic (who fulfilled diagnostic criteria), four studies described 
individuals who were treated with cross-sex hormones who fulfilled the diagnosis, 
five studies described individuals who had or were referred for sex reassignment 
surgery (SRS) and five studies collected information regarding the possible number of 
transsexual individuals by accessing Governmental organizations, i.e. the bureau of 
records or virtual statistics. In spite of the complication of reaching a clear diagnosis, 
most studies were able to provide the estimate of the number of transsexual 
individuals, trans men and trans women from the age of 15 years.  
 
3.3. Prevalence of transsexualism 
Out of the 21 studies selected, 20 provided information on the number of transsexual 
individuals in their study and gave information about the population that the clinic or 
studied area covered. The American study(16) provided only an approximation of trans 
individuals. Although it is historically important, it does not provide enough 
information for analysis. As explained above, studies using the same database, but at 
different time periods were removed for this analysis and only the most recent ones 
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selected. Therefore out of the 20 studies, 12 provided enough new data on prevalence. 
Those studies provided point prevalence as they reported the number of transsexual 
individuals at the point when the study took place by reporting the number of 
individuals since the clinic opened or records began. The prevalence of trans 
individuals was studied in 12 countries with a total population of 95,141,541 
individuals. The largest population studied was in West Germany with nearly 35 
million individuals included(43). There was a similar group of natal males and females 
within the overall general population with 30,651,864 males and 31,689,246 females.  
 
The 12 studies identified a total of 4355 trans individuals. The largest number of trans 
individuals were identified in the German study that looked at gender identity clinics 
in specific areas of Germany, with a total of 1773 trans individuals(13). However, this 
study did not provide the highest prevalence of transsexual individuals per 100,000 
people. Rather, this was reported in the Singaporean study (23.60 Singapore-born 
trans individuals per 100,000 people(23). This study may underestimate the total 
number of trans individuals in Singapore, as it only includes those who go for sex-
reassignment surgery, which is only a proportion of all trans people. Not 
unexpectedly, more recent studies found higher prevalence rates than older studies. 
As an example, the recent Swedish study found a prevalence of 16.67 per 100,000(17).  
 
Meta-analysis found an overall prevalence of transsexualism using random effects 
meta-analysis of 0.000046 (95% CI= 0.000028-0.000077). Heterogeneity was high (I² 
= 99.6%; Q value=3314.7) therefore the random effect was selected. This indicates a 
prevalence of transsexualism of 4.6 per 100,000 or 1 in every 21,739 individuals. 
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Insert table 2 around here 
 
3.4. Prevalence of trans women 
All studies identified a higher prevalence of trans women compared to trans men, 
with the exception of the study by Godlewski(48) with a score of (-). Prevalence rates 
of trans women varied between 0.44(22) and 35.2 per 100,000(23). 
 
As one of the studies did not report the number of female or male individuals in the 
population studied, this study was removed from subsequent analysis(43). Therefore, 
eleven studies were included in the meta-analysis. An overall prevalence rate of 
0.000068 (95% CI= 0.00004 – 0.00010) of trans women was found. Heterogeneity 
was high (I² = 99.0%; Q value=1070.35) therefore random effect was selected. This 
indicates a prevalence of trans women of 6.8 per 100,000 or 1 in every 14,705 
individuals. 
 
Insert Table 3 around here 
 
3.5. Prevalence of trans men 
Most studies reported a smaller number of trans men when compared to trans women. 
Prevalence rates varied from 0.25(16) to 6.64 per 100,000(17). The trans women to trans 
men ratios varied from 6.1 trans women to every one trans men (6:1)(49) to 1 to 1 
(1:1)(46).  
 
Eleven studies were included in the meta-analysis. An overall prevalence rate of 
0.000026 (95% CI= 0.000017 – 0.00004) was found. Heterogeneity was also high (I² 
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= 97.7%; Q value=435.1). This indicates a prevalence of trans men of 2.6 per 100,000 
or 1 in every 38,461 individuals. Using meta-analytical prevalence rates, the ratio of 
trans women to trans men was found to be 2.6 trans women for every trans man 
(2.6:1). 
 
Insert table 4 around here 
 
Insert table 5 around here 
 
3.6. Change of prevalence rates over the years 
For the time series analysis 17 studies that provided period prevalence data at 
different time points were included. Most of the studies provided data from a period 
of time between 4 and 10 years. In order to undertake time series analysis a regression 
analysis was undertaken with date as a moderator variable. The date selected was 
calculated as the mean of the numbers of years of the study period. Time series 
analysis showed a statistically significant effect for general transsexualism (z=23.45, 
p < 0.001), trans women (z = 22.13, p < 0.001), and trans men (z = 8.00, p < 0.001) 
suggesting a higher prevalence of transsexual individuals, trans women and trans men 
in more recent studies. 
 
Insert figure 2 around here 
 
4. Discussion 
This is the first study that has aimed to critically review and meta-analytically 
investigate the prevalence of transsexualism. Twenty-one studies were identified as 
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having enough data and using similar diagnostic criteria suitable for a critical review, 
with 12 studies having enough data to perform a meta-analysis. Most epidemiological 
studies in this area have investigated the prevalence rates of HIV in this 
population(51,52,53) and very few have investigated the number of trans people in the 
general population, which may be due to the complex methodology required to 
undertake such studies.   
This study showed that there has been a clear increase in the prevalence of individuals 
diagnosed with transsexualism over time, with newer studies reporting statistically 
significant higher rates than older studies. Countries using the same database over the 
years have reported an increased prevalence of individuals attending clinical services, 
receiving prescribed cross-sex hormones, or applying for sex reassignment surgery. 
The overall meta-analytical prevalence of transsexualism was found to be 4.6 per 
100,000, with the meta-analytical prevalence of trans women being higher (6.8 in 
100,000) than that of trans men (2.6 in 100,000). Although the sex ratio has moved 
closer to 1:1, using the meta-analytical prevalence, the trans women to trans men ratio 
was calculated to be 2.6 to 1.  
 
The increase in prevalence over the years is likely due to several factors: the increased 
visibility of trans people in the media, which likely contributes to at least a partial 
destigmatization of being trans(54); the wide availability of information on the Internet 
about transsexualism or Gender Dysphoria, which also likely contributes to 
destigmatization(54); the increased awareness of the availability of biomedical 
treatment(4,5, 20); and the development of societal tolerance towards trans 
individuals(15).  With regards to the latter, most of the studies investigating social 
attitudes to gender and sexual diversity have primarily explored peoples’ attitudes 
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towards gay, lesbian, and bisexual (LGB) individuals. The 2012 edition of the 
Eurobarometer however, included questions aiming at measuring the public attitudes 
to transgender people in European countries for the first time. The most tolerant 
countries appear to be Denmark, Luxembourg, Ireland, Sweden and the United 
Kingdom.  Interestingly, the proportion of individuals who feel uncomfortable with 
trans people was larger than for LGB people in all European countries.  In six 
European countries the majority of people report to feel comfortable with a trans 
person as a government leader: Denmark, Sweden, Luxembourg, Spain, the United 
Kingdom and the Netherlands(15). This report is the first to specifically explore 
societal tolerance towards trans people.  
Recent reports indicate that the number of individuals with gender dysphoria who 
attend clinical services for an assessment has increased substantially over the years in 
many European countries(54,55).  There is also a significant increase in people who 
self-diagnose as suffering from gender dysphoria(19). Although this review did not 
include studies of people who self-diagnose, such studies are important as they may 
indicate the level of future demand for clinical services. For example Kuyper and 
Wijsen(19) found that 4.6% of natal men and 3.2% of natal women in their Dutch 
population sample reported an ambivalent gender identity (equal identification with 
other sex as with sex assigned at birth) and 1.1% of the natal men and 0.8% of the 
natal women reported an incongruent gender identity (stronger identification with 
other sex as with sex assigned at birth). It remains unknown how many of their 
sample will seek assessment and treatment via a gender identity clinic service. 
 
Many trans individuals require clinical services as they wish to have cross-sex 
hormone treatment and surgery to alleviate their gender dysphoria.  However, some 
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feel that only one of these treatment modalities is necessary for them, whilst others 
may decide to not take cross-sex hormones or undergo any operations(56, 57).
 
Psychotherapy can be helpful for some individuals to integrate their transgender 
feelings into their gender role assigned at birth and do not feel the need to feminize or 
masculinize their body; for those changes in social gender role and expression can be 
sufficient to alleviate gender dysphoria(20,57). Moreover, many trans individuals may 
have socially transitioned with or without partial treatment through self-prescribed 
cross sex hormones or private means(58,59).   
 
The complex care pathway of trans individuals, makes the organization of service 
delivery difficult to plan ahead. The prevalence of people requiring assessment and 
treatment for gender dysphoria may be more accurately estimated by looking at 
community studies. Studies reporting prevalence rates of SRS are likely to 
underestimate the true prevalence of transsexualism in the community. Since one of 
the largest studies in this meta-analysis identified their participants via applications 
for SRS(21) , the overall prevalence rate is likely to be higher than the one reported in 
this meta-analysis. 
 
The main strength of this paper is the fact that this is the first study that summarizes 
and critically assesses all the available data in the subject of trans epidemiology 
taking into consideration the weight of the study in the analysis, in order to avoid 
biased results based on large studies. While studies have become methodologically 
stronger over the years, this review and meta-analysis is limited by the available data. 
The majority of the studies were conducted in Western countries, particularly in 
Europe, and the results may be related to the level of tolerance of society, the 
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healthcare system available, legislation regarding the rights of trans people and the 
academic interest in the area of trans healthcare. This is clearly reflected by the large 
body of research originating from Europe, particularly in Sweden and the 
Netherlands. There are a limited number of reports regarding trans individuals from 
developing countries(60, 61, 62, 63).
 This may simply indicate that while trans individuals 
do indeed have access to services, no epidemiological studies have been undertaken. 
Alternatively, for some countries it may indicate that there are no clinical services 
available and that trans individuals in these areas need to suppress their real self, the 
consequence of which may be the development of mental health problems(64, 65, 66). 
 
The study is limited by the high heterogeneity of the included studies, which is not 
surprising as there are clear differences between the methodology of the studies 
included in the review. This is reflected in the great variation of prevalence data from 
the different studies. We use a random effects model in an effort to incorporate 
heterogeneity between the studies in our analysis but recognize that this does not 
eliminate the fact that heterogeneity was present.  In spite of the limitations of this 
meta-analytical study, and the majority of the prevalence studies reviewed, the 
existing data should be considered as a starting point. The field would benefit from 
more rigorous epidemiological studies acknowledging current changes in 
classification system and including different locations worldwide.  
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Table 1: Criteria for searches on prevalence of Transsexualism   
Category Criteria 
Study population All races, ethnicities, and cultural groups 
Adults (>18 years) or adolescents (18-15 
years); no children (<15 years) 
Study settings and geography All nations 
Time period Published from 1954 through June 2014 
Publication criteria Included: 
- All languages 
- Articles in print or online 
Excluded: 
- Articles in grey literature or non-peer-
reviewed journals or unobtainable during 
the review period 
Admissible evidence 
(Study design and 
other criteria) 
Transsexualism, Gender Identity Disorder 
or Gender Dysphoria must be diagnosed 
according to DSM III, DSM III-R, DSM 
IV, DSM-IV-TR, DSM-V, ICD-9, ICD-10, 
or Benjamin criteria. 
Prevalence must be available or be able to 
be extracted from the data. 
 
Country, number of years used to extract 
the data, number of trans individuals, natal 
or preferred gender, mean age, general 
population of the studied area (divided by 
natal males and female), to be recorded 
when possible. 
 
Eligible study designs include: 
Table 1
Observational studies including descriptive 
studies, evidence that the population 
described belongs to a defined area, region 
or country. 
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